Drug Patents owned by Javelin Pharms Inc

1. List of Dyloject drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8946292 JAVELIN PHARMS INC Formulations of low dose diclofenac and beta-cyclodextrin
Mar, 2027

(4 years from now)

Drugs and Companies using DICLOFENAC SODIUM ingredient

Market Authorisation Date: 23 December, 2014

Treatment: Management of pain

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of DYLOJECT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in